Repairing the cartilage protective layer to help osteoarthritis
Official title: Molecular Engineering of Cartilage PCM Mechanotransduction in Osteoarthritis Using Biomimetic Proteoglycans
Funded at Villanova University · NIH-11136294 · Data updated 2026-11-12
Researchers are developing lab-made molecules that mimic cartilage sugars to rebuild the tiny protective layer around joint cells for people with osteoarthritis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Villanova University NIH-funded |
| Lab location | 1 site (Villanova, United States) |
| Project start | July 10, 2022 |
| Project end | December 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $278,409 |
| NIH project number | 5R01AR080139-04 |
| Project ID | NIH-11136294 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with osteoarthritis—especially those with early to moderate cartilage degeneration in a knee or other joint—would be the most relevant candidates for future clinical steps related to this work.
✕Less likely to help
Patients with very advanced joint destruction or those already scheduled for immediate joint replacement are less likely to benefit from this approach.
What this research studies
This project makes biomimetic proteoglycans—lab-designed molecules that copy the sugar–protein structure of healthy cartilage—and applies them to damaged cartilage. Scientists will test these molecules in three-dimensional cartilage cell cultures and experimental models that mimic osteoarthritis to see if they restore the pericellular matrix, the small protective zone around each cartilage cell. Restoring that zone could help cells sense mechanical load normally and promote new cartilage matrix formation. The work combines chemistry, cell biology, and engineered tissue models to measure structural and functional recovery.
Why it matters
Potential benefit: If successful, this approach could help rebuild damaged cartilage, reduce pain or slow osteoarthritis progression, and potentially delay or avoid joint replacement surgery.
How similar studies have gone: Early laboratory and animal work on PCM-targeting and biomimetic proteoglycans has shown promise in restoring matrix properties, but clinical benefits in people have not yet been demonstrated.
Where this research is happening
-
Villanova University
Villanova, United States Active
Researchers
- Principal investigator: Marcolongo, Michele S — Villanova University
- Study coordinator: Marcolongo, Michele S
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.